TARGETED IMMUNOMODULATION Trademark

Trademark Overview

On Tuesday, September 27, 2016, a trademark application was filed for TARGETED IMMUNOMODULATION with the United States Patent and Trademark Office. The USPTO has given the TARGETED IMMUNOMODULATION trademark a serial number of 87185250. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Wednesday, August 29, 2018. This trademark is owned by Compass Therapeutics LLC. The TARGETED IMMUNOMODULATION trademark is filed in the Education & Entertainment Services category with the following description:

Educational services, namely, providing a website featuring resources, namely, non-downloadable articles in the field of medical research
targeted immunomodulation

General Information

Serial Number87185250
Word MarkTARGETED IMMUNOMODULATION
Filing DateTuesday, September 27, 2016
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateWednesday, August 29, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesEducational services, namely, providing a website featuring resources, namely, non-downloadable articles in the field of medical research

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateFriday, September 30, 2016
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCompass Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Tuesday, September 11, 2018ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Wednesday, August 29, 2018ABANDONMENT - AFTER EX PARTE APPEAL
Wednesday, August 29, 2018EXPARTE APPEAL TERMINATED
Monday, July 16, 2018EXPARTE APPEAL DSMSED - FAILURE TO FILE BRIEF
Thursday, March 1, 2018NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Thursday, March 1, 2018ACTION DENYING REQ FOR RECON E-MAILED
Thursday, March 1, 2018ACTION CONTINUING FINAL - COMPLETED
Tuesday, February 13, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 13, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 12, 2018ASSIGNED TO LIE
Monday, February 5, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, February 5, 2018EX PARTE APPEAL-INSTITUTED
Monday, February 5, 2018JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, February 5, 2018EXPARTE APPEAL RECEIVED AT TTAB
Friday, August 4, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, August 4, 2017FINAL REFUSAL E-MAILED
Friday, August 4, 2017FINAL REFUSAL WRITTEN
Thursday, July 13, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 10, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 10, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 9, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 9, 2017NON-FINAL ACTION E-MAILED
Monday, January 9, 2017NON-FINAL ACTION WRITTEN
Wednesday, January 4, 2017ASSIGNED TO EXAMINER
Friday, September 30, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 30, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

immunomodulation targeted namely articles field medical downloadable research featuring services providing website